Showing posts with label biopharmaceuticals. Show all posts
Showing posts with label biopharmaceuticals. Show all posts

Tuesday, 21 June 2011

ERT Appoints Robert Kleiman MD to Chief Medical Officer

PHILADELPHIA, PA – 21 June, 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that Robert Kleiman, M.D.  has been appointed to the role of Chief Medical Officer in addition to his current role as Vice President of Global Cardiology.

Dr. Kleiman graduated from Brown University Medical School with residency in Internal Medicine and completed Fellowships in Cardiology and Cardiac Electrophysiology at the University of Pennsylvania. Prior to joining ERT as a full time employee in April 2004, Dr. Kleiman had worked for ERT as an independent contractor through his cardiology and cardiac electrophysiology practice since 1994.  Dr. Kleiman has managed ERT’s cardiology group, which has more than tripled in size since 2004, while maintaining ERT’s standards for high quality and consistency.